title: New advances in pharmacogenomics.
abstract: In the years to come, pharmacogenomics will make an impact on the development of new drugs. Numerous publications have shown that gene polymorphism can influence drug toxicity and/or efficacy. In order to improve current applications of pharmacogenomics, some technical limitations regarding marker generation, genotyping and biostatistical analysis are being overcome.
authors.affiliation: GENSET SA, Genomic Research Centre, Department of Pharmacogenomics and Medical Affairs, Evry, France.
authors.forename: B
authors.initials: B
authors.lastname: Destenaves
authors.forename: F
authors.initials: F
authors.lastname: Thomas
mesh_terms: D015195:Drug Design; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions / Q000235:genetics; D014644:Genetic Variation; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide / Q000235:genetics